MY195494A - Composition For Eradicating Helicobacter Pylori - Google Patents

Composition For Eradicating Helicobacter Pylori

Info

Publication number
MY195494A
MY195494A MYPI2021000995A MYPI2021000995A MY195494A MY 195494 A MY195494 A MY 195494A MY PI2021000995 A MYPI2021000995 A MY PI2021000995A MY PI2021000995 A MYPI2021000995 A MY PI2021000995A MY 195494 A MY195494 A MY 195494A
Authority
MY
Malaysia
Prior art keywords
composition
helicobacter pylori
eradicating helicobacter
eradicating
present
Prior art date
Application number
MYPI2021000995A
Other languages
English (en)
Inventor
Bong Tae Kim
Dongkyu Kim
Eun Ji Kim
Ji Won Lee
Kyeongmin Oh
Ahrong Kim
Geun Seog Song
Shin-Young Ryu
Eun Kyung Kim
Naree Shin
Hyun Ji Kang
Jae Min Kim
Yu-Gyeong Park
Haneul Jeong
Original Assignee
Hk Inno N Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hk Inno N Corp filed Critical Hk Inno N Corp
Publication of MY195494A publication Critical patent/MY195494A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
MYPI2021000995A 2018-08-29 2019-08-28 Composition For Eradicating Helicobacter Pylori MY195494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180102250 2018-08-29
PCT/KR2019/011017 WO2020045992A1 (en) 2018-08-29 2019-08-28 Composition for eradicating helicobacter pylori

Publications (1)

Publication Number Publication Date
MY195494A true MY195494A (en) 2023-01-26

Family

ID=69643254

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021000995A MY195494A (en) 2018-08-29 2019-08-28 Composition For Eradicating Helicobacter Pylori

Country Status (19)

Country Link
US (1) US20210196685A1 (es)
EP (1) EP3843723A4 (es)
JP (1) JP7189327B2 (es)
KR (1) KR20200026118A (es)
CN (1) CN112638378A (es)
AR (1) AR116026A1 (es)
AU (1) AU2019328903B2 (es)
BR (1) BR112021003578A2 (es)
CA (1) CA3107624C (es)
EA (1) EA202190622A1 (es)
GE (1) GEP20227431B (es)
JO (1) JOP20190201A1 (es)
MX (1) MX2021002278A (es)
MY (1) MY195494A (es)
PH (1) PH12021550385A1 (es)
SG (1) SG11202101920WA (es)
UA (1) UA126993C2 (es)
UY (1) UY38348A (es)
WO (1) WO2020045992A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20180094A1 (ar) 2017-10-18 2019-04-18 Hk Inno N Corp مركب حلقي غير متجانس كمثبط بروتين كيناز
CN113939293A (zh) * 2019-04-18 2022-01-14 托马斯·朱利叶斯·波洛迪 用于治疗、改善和预防幽门螺杆菌感染的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753324B2 (en) * 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
KR101088247B1 (ko) * 2005-12-19 2011-11-30 라퀄리아 파마 인코포레이티드 크로메인 치환된 벤즈이미다졸 및 이들의 산 펌프억제제로서의 용도
CN101015694A (zh) * 2006-02-07 2007-08-15 沈阳东宇药业有限公司 一种治疗幽门螺旋杆菌感染的复方口服制剂
KR20160144927A (ko) * 2015-06-08 2016-12-19 씨제이헬스케어 주식회사 야간 산 분비에 대한 벤즈이미다졸 유도체의 용도
US11096948B2 (en) * 2016-01-21 2021-08-24 Dexcel Pharma Technologies Ltd. Methods for treating helicobacter infection
KR101829706B1 (ko) * 2016-09-21 2018-02-19 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 산부가염
CN108379258B (zh) * 2017-11-30 2020-02-18 中国医学科学院医药生物技术研究所 瑞香素在抗幽门螺杆菌中的应用

Also Published As

Publication number Publication date
UA126993C2 (uk) 2023-03-01
JP7189327B2 (ja) 2022-12-13
UY38348A (es) 2020-03-31
AU2019328903A1 (en) 2021-04-29
KR20200026118A (ko) 2020-03-10
AU2019328903A8 (en) 2021-05-27
EP3843723A4 (en) 2022-06-29
JP2021535910A (ja) 2021-12-23
EA202190622A1 (ru) 2021-06-10
AU2019328903B2 (en) 2023-01-05
US20210196685A1 (en) 2021-07-01
MX2021002278A (es) 2021-08-11
CA3107624A1 (en) 2020-03-05
CA3107624C (en) 2023-10-03
EP3843723A1 (en) 2021-07-07
JOP20190201A1 (ar) 2020-02-29
BR112021003578A2 (pt) 2021-05-18
CN112638378A (zh) 2021-04-09
WO2020045992A1 (en) 2020-03-05
SG11202101920WA (en) 2021-04-29
GEP20227431B (en) 2022-10-25
PH12021550385A1 (en) 2021-09-20
AR116026A1 (es) 2021-03-25

Similar Documents

Publication Publication Date Title
SA519402400B1 (ar) تركيبات وطرق لعلاج أمراض الهيموجلوبين
MX2022012155A (es) Composiciones de endofitos y metodos para mejorar las caracteristicas de las plantas.
PH12020550839A1 (en) Spray-dried sialyllactose
PH12018502014A1 (en) Vapour provision device
MX2019010349A (es) Composiciones de endofitos y metodos para mejorar las caracteristicas de las plantas.
EA202191765A1 (ru) Композиция для наружного применения, включающая жизнеспособные микроорганизмы
MX2023009561A (es) Moduladores de profarmacos de la via de estres integrada.
PH12021550385A1 (en) Composition for eradicating helicobacter pylori
MX2020002782A (es) Sello para cables y disposicion con un alojamiento.
EP3817544A4 (en) CANNABIS VARIETY THAT PRODUCES MORE THAN 50% FEMALE PLANTS
MX2018010266A (es) Métodos, dispositivos y sistemas para procesamiento de composiciones carbonosas.
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
EP3551186A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT, IMPROVEMENT AND PREVENTION OF H. PYLORI INFECTIONS
WO2017214240A3 (en) Cleaning compositions having an enzyme system
MX2021006674A (es) Composiciones para estabilizar bacterias y usos de las mismas.
PH12019502174A1 (en) Modulators of pcsk9 expression
PH12020551995A1 (en) Modulator of apol1 expression
SG11201907472QA (en) Composition for inhibiting myofibrosis
MX2021005120A (es) Formulacion aerosolizada.
Kurbanov The main role of professional competence teacher of the modern times
MX2020007369A (es) Moduladores de la expresion de dnm2.
NZ763603A (en) Flavoured vaporisable formulation
PH12018500646A1 (en) Viscoelastic composition
EP3955927A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT, MITIGATION AND PREVENTION OF H. PYLORI INFECTION
MY194673A (en) Additive for hydraulic composition